News

Medscape15h
FDA Approves Penpulimab for Nasopharyngeal Cancer
Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...
Fierce Pharma15h
Akeso, Sino Biopharm’s Anniko enters crowded PD-1 market with FDA approval in head and neck cancer subtype
Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso has won the FDA’s go-ahead for ...
Contract Pharma17h
FDA Approves Akeso’s Penpulimab for Nasopharyngeal Carcinoma
The FDA has approved Akeso Inc.’s penpulimab-kcqx in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or metastatic NPC.
Defining Personhood, The Next Phase In The Fight For Reproductive Rights
It's been three years since Roe v. Wade was overturned by the Supreme Court.The abortion access landscape has changed dramatically in that time. The procedure has been banned in 12 states with limited ...
ALS News Today4d
First patient dosed in a Phase 1 study testing AMX0114 in ALS
AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...